Sumitovant Biopharma Ltd., 10% Owner at Myovant Sciences Ltd. (MYOV), bought 203,850 shares at $22.13 ($4.4M) on 2021-08-23, disclosed to the SEC on 2021-08-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.86 | 46,478 | $970K | 22.0% |
| 2 | $20.86 | 46,478 | $970K | 22.0% |
| 3 | $22.13 | 25,057 | $555K | 12.6% |
| 4 | $22.13 | 25,057 | $555K | 12.6% |
| 5 | $22.45 | 30,390 | $682K | 15.5% |
| 6 | $22.45 | 30,390 |
| $682K |
| 15.5% |
| Total | $21.65 avg | 203,850 | $4.4M | 100% |
| Filing → |
| MYOV | BUY | 2021-09-16 | $7.1M | — | Filing → |
| MYOV | BUY | 2021-09-08 | $3.4M | — | Filing → |
| MYOV | BUY | 2021-08-26 | $2.8M | — | Filing → |